Kyle Bowman

Kyle Bowman is a seasoned professional in the healthcare and life sciences industry with extensive experience in patient access, commercialization, and strategic planning. Currently serving as Senior Director of Policy, Evidence, and Access Strategy in Ophthalmology at Genentech, Kyle leads a team focused on pricing, contracting, and distribution strategies to enhance patient access to critical therapies. Previous roles at Genentech included Director of Access & Policy Strategy, managing the commercialization of Alzheimer's and neuroimmunology portfolios, and Senior Strategy Manager for the Alzheimer's pipeline and respiratory portfolio. Prior to Genentech, Kyle held leadership positions at CVS Health, overseeing pharmacy strategy and business development, and began a career in strategy consulting with Deloitte. Kyle holds an MBA from the University of California, Berkeley, and a Bachelor of Science degree from Miami University.